New Two-Pronged radiation attack tested for prostate Cancer's return
NCT ID NCT06105918
Summary
This early-stage study is testing the safety of a new two-part treatment for prostate cancer that has returned after surgery. Six patients will receive targeted external beam radiation followed by an injected radioactive drug designed to seek out and destroy remaining cancer cells. The main goal is to see if this combination is safe and to find the best dose of the injected drug.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Emory University Hospital/Winship Cancer Institute
Atlanta, Georgia, 30322, United States
Conditions
Explore the condition pages connected to this study.